13
Participants
Start Date
December 20, 2023
Primary Completion Date
December 6, 2024
Study Completion Date
May 31, 2025
Subcutaneous azacitidine
Subcutaneous azacitidine, 75mg/m2, 7 days
Oral decitabine/cedazuridine
Oral decitabine 35mg/cedazuridine 100mg, once daily, 5 days
Calvary Mater Newcastle, Newcastle
Pindara Private Hospital, Benowa
Townsville Hospital, Townsville
Adelaide Oncology and Haematology, North Adelaide
Grampian Health (Ballarat Base Hospital), Ballarat Central
Latrobe Regional Hospital, Traralgon
Christchurch Hospital, Christchurch
Dunedin Hospital, Dunedin
Auckland City Hospital, Grafton
Waikato Hospital, Hamilton
North Shore Hospital (Waitemata District Health Board), Takapuna
Otsuka Australia Pharmaceutical Pty Ltd
INDUSTRY